Jun 11 |
BOTOX® Cosmetic (onabotulinumtoxinA) Reveals 2024 Women Entrepreneur Grant Recipients
|
Jun 7 |
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
|
Jun 7 |
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
|
Jun 7 |
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades'
|
Jun 7 |
AbbVie-partnered therapy selected for FDA’s rare disease pilot program
|
Jun 7 |
Geron wins long-sought drug approval; Califf talks China, GLP-1s at BIO
|
Jun 7 |
AbbVie reports positive Phase II ovarian cancer trial data
|
Jun 6 |
Is AbbVie Inc. (NYSE:ABBV) the Most Undervalued Dividend Aristocrat Stock According to Analysts?
|
Jun 6 |
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
|
Jun 6 |
AbbVie succeeds in mid-stage trial for ovarian cancer drug, Elahere
|